Mycrodose Therapeutics Successfully Delivers Both Macro and Microdose Levels of Psilocin Using Core Drug Delivery Technologies

San Diego, California--(Newsfile Corp. - May 10, 2022) - Mycrodose Therapeutics showed the ability to synthesize and stabilize psilocin in their laboratory for use in their IP-protected drug delivery

Related Keywords

California ,United States ,San Diego ,Kostenloser Wertpapierhandel ,Patrick Eckstrom ,Frank Kochinke ,Bryan Arrayales ,Mycrodose Therapeutics Inc ,California Newsfile Corp ,Microdosing Technology ,Chief Science Officer ,Mycrodose Therapeutics ,Protected Sustained Microdosing Technology ,Mycrodose ,Herapeutics ,Uccessfully ,Elivers ,Moth ,Macro ,Imicrodose ,Levels ,Psilocin ,Sing ,More ,Drug ,Delivery ,Technologies ,